SCHEMBL3757138

SCHEMBL3757138

CNC(=O)c1cccc(-c2cnn3c(-c4ccnc(Cl)c4)c([AsH2])nc3c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.50
FGFR3 P22607 2/20 0.50
CDK8 P49336 1/20 0.45
NR4A2 P43354 1/20 0.43
KDM5A P29375 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
KDM5B Q9UGL1 1/20 0.42
MAPK14 Q16539 7/20 0.41
MAPK13 O15264 6/20 0.41
MAPK12 P53778 6/20 0.41
MAPK11 Q15759 6/20 0.41
FYN P06241 4/20 0.41
NTRK1 P04629 1/20 0.40
PDGFRB P09619 1/20 0.40
KIT P10721 1/20 0.40
FLT3 P36888 1/20 0.40
PIP5K1C O60331 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CG P48736 1/20 0.39
PDE4A P27815 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL835076 0.91 FGFR1 (0.48) FGFR1FGFR3CDK8NR4A2KDM5A
SCHEMBL837206 0.84 FGFR3 (0.70) FGFR1FGFR3CDK8FYNNTRK1
SCHEMBL2347266 0.80 FGFR1 (0.64) FGFR1FGFR3NR4A2FYNNTRK1
SCHEMBL835756 0.79 FGFR1 (0.48) FGFR1FGFR3CDK8NR4A2KDM5A
SCHEMBL835840 0.74 FGFR3 (0.73) FGFR1FGFR3CDK8FYNNTRK1
SCHEMBL12448288 0.74 FGFR1 (0.66) FGFR1FGFR3CDK8NR4A2FYN
SCHEMBL837839 0.73 FGFR1 (0.65) FGFR1FGFR3CDK8NR4A2FYN
SCHEMBL834829 0.73 FGFR1 (0.70) FGFR1FGFR3CDK8FYNNTRK1
SCHEMBL2340954 0.72 FGFR3 (0.66) FGFR1FGFR3CDK8FYNNTRK1
SCHEMBL837898 0.71 CDK8 (0.55) FGFR1FGFR3CDK8NR4A2KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183027-A1 ORGANIC COMPOUNDS Novartis Ag (CH) 2010-05-12 EP disclosed
WO-2009013335-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-01-29 WO disclosed